-- Sanofi Says Rifapentine Tuberculosis Treatment Gets European Orphan Status
-- David Whitehouse
-- 2010-07-01T05:08:13Z
-- http://www.bloomberg.com/news/2010-07-01/sanofi-says-rifapentine-tuberculosis-treatment-gets-european-orphan-status.html

          
          
             Sanofi-Aventis SA said that its
rifapentine treatment has been granted orphan drug status by the
European Commission for Treatment of Tuberculosis.  
 The news came in an emailed statement.  
          
          


  


        